Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01710306 · ClinicalTrials.gov registry record · NA

Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care

A NA study of PTSD, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
171
Enrollment target
1
Study location

NCT01710306: Completed NA study of PTSD, sponsored by VA Office of Research and Development.

NCT01710306 is a NA study of PTSD that has completed, run by VA Office of Research and Development. The registered enrollment target is 171 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01710306, a NA study of PTSD, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
171 participants
Enrollment target
1
Study location

Study Summary

Women and Reserve/National (RNG) Veterans are among the fastest growing groups of new VA users. While PTSD is prevalent in this group, most women don't access or complete needed treatment. This study will investigate Operation enduring/Iraqi Freedom and New Dawn (OEF/OIF/OND) RNG female war Veterans' perceptions, preferences, barriers and facilitators to accessing VA mental health (MH) and evidence-based PTSD psychotherapy. This information will be used to revise an existing web-based screen that educates participants about their unique post-deployment MH conditions. This web-interface will then be used to randomly assign women who screen positive for PTSD to either 1) a concierge nurse case manager who uses shared decision-making to engage Veterans in EBP or 2) usual outreach to determine what engagement approach women prefer. The investigators' findings will provide VA leaders with key information to understand and improve access to RNG PTSD treatment.

Primary Outcome

VA mental health care engagement is defined as participation in any of the following: PTSD psychotherapy, cognitive processing therapy, or prolonged exposure therapy. To be identified in VA electronic medical record

Conditions Studied

Interventions

  • BEHAVIORAL Nurse Care Manager (NCM)

Study Locations (1)

Iowa

  • Iowa City VA Health Care System, Iowa City, IA - Iowa City

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2013-09-01
Est. Completion 2017-06-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01710306 record still lists

NCT01710306 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (43% lower).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Nurse Care Manager (NCM) is the first listed.

NCT01710306 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT01710306 about?

NCT01710306 is a clinical study titled "Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care". Women and Reserve/National (RNG) Veterans are among the fastest growing groups of new VA users. While PTSD is prevalent in this group, most women don't access or complete needed treatment. This study will investigate Operation enduring/Iraqi Freedom and New Dawn (OEF/OIF/OND) RNG female war Veterans...

What is the current status of trial NCT01710306?

This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2013-09-01. Estimated completion is 2017-06-30.

What conditions does trial NCT01710306 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT01710306?

The interventions under investigation include: Nurse Care Manager (NCM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01710306?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01710306 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01710306's enrollment target sits among peer trials

171 36th of 154 higher than 119 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01710306, the US trial registry maintained by the National Library of Medicine. NCT01710306 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.